Accordingly, recent studies indicated that GPX4 could also promote HCC development via inhibiting ferroptosis (Kim et al., 2020; Alves et al., 2021; Asperti et al., 2021; Chang et al., 2021). Here, GPX4 is linked to hepatocellular carcinoma.